The Enterprise Value as of September 2024 (TTM) for Editas Medicine, Inc. (EDIT) is 270.35M

According to Editas Medicine, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 270.35M. This represents a change of -51.82% compared to the average of 561.17M of the last 4 quarters.

Editas Medicine, Inc. (EDIT) Historical Enterprise Value (quarterly & annually)

How has EDIT Enterprise Value performed in the past?

The mean historical Enterprise Value of Editas Medicine, Inc. over the last ten years is 1.15B. The current 270.35M Enterprise Value has changed 2.25% with respect to the historical average. Over the past ten years (40 quarters), EDIT's Enterprise Value was at its highest in in the December 2020 quarter at 4.24B. The Enterprise Value was at its lowest in in the September 2014 quarter at 0.

Editas Medicine, Inc. (EDIT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Editas Medicine, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Editas Medicine, Inc. (EDIT) Average Enterprise Value

How has EDIT Enterprise Value performed in the past?

The current Enterprise Value of Editas Medicine, Inc. (EDIT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Editas Medicine, Inc. (EDIT) Enterprise Value vs. Peers

How is EDIT’s Enterprise Value compared to its peers?

Editas Medicine, Inc.’s Enterprise Value is less than Beam Therapeutics Inc. (1.79B), less than CRISPR Therapeutics AG (3.55B), greater than Caribou Biosciences, Inc. (144.89M), less than Verve Therapeutics, Inc. (404.46M), less than Intellia Therapeutics, Inc. (1.98B), less than Prime Medicine, Inc. (412.09M), less than Vertex Pharmaceuticals Incorporated (117.15B), less than Ginkgo Bioworks Holdings, Inc. (694.60M), less than Allogene Therapeutics, Inc. (427.50M), less than Sana Biotechnology, Inc. (1.08B),

Build a custom stock screener for Editas Medicine, Inc. (EDIT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Editas Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Editas Medicine, Inc. (EDIT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Editas Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.